KLOXXADO® Nasal Spray – 8mg Naloxone Emergency Overdose Reversal
KLOXXADO® (naloxone HCl) Nasal Spray 8mg provides critical emergency intervention for suspected opioid overdose situations. This FDA-approved naloxone formulation is specifically designed to rapidly reverse the life-threatening effects of opioid overdose in both adult and pediatric patients.
Key Product Features:
- Higher-concentration 8mg naloxone hydrochloride formulation
- Ready-to-use nasal spray device requiring no assembly
- Rapid-acting opioid antagonist technology
- Safe to administer even when opioids may not be present
- Approved for emergency use in adults and children
Emergency Response Applications: Essential for first responders, healthcare facilities, educational institutions, and workplace safety programs. KLOXXADO® supports comprehensive overdose prevention strategies in environments where opioid exposure risks exist.
Clinical Indication: Indicated for emergency treatment of known or suspected opioid overdose characterized by respiratory and/or central nervous system depression. Designed for immediate administration in emergency settings where opioids may be present.
Important Safety Information: KLOXXADO® is intended for emergency use only and is not a substitute for emergency medical care. Always contact emergency services immediately when administering. Proper training on overdose recognition and administration procedures is recommended.
